Adderall one of many drugs, medical supplies at risk
Resilinc
NOVEMBER 22, 2022
In October, the FDA announced a shortage of ADHD drug Adderall, with leading manufacturer Teva Pharmaceuticals forecasting that its generic brands would be in short supply until March 2023. This weakness was highlighted by the Biden Administration in its June 2021 supply chain report.
Let's personalize your content